The Albanese government is facing calls to scrap or fundamentally rework key parts of its proposed changes to the R&D tax incentive to avoid undermining Australia’s vibrant deep tech...
CSIRO-backed venture capital firm Main Sequence has contributed to a $9.25 million funding round for an Australian biotechnology startup tackling pain and agitation in dementia patients. Main Sequence has...
Anthropic has quietly set up a laboratory to do physical biology work as it pushes its artificial-intelligence ambitions into the world of drug science. At a time when fears...
Opening a new Brisbane headquarters and accredited laboratory is a significant step for any growing biotech company. For Genics, the move also shows how far a piece of Australian...
A coalition of research groups, accelerators and incubators have united to urge the Albanese government to rethink changes to the R&D Tax Incentive that will limit refundability to startups...
Cynata Therapeutics has laid off its entire staff after a clinical trial of its stem cell therapy failed to outperform a placebo, dealing a fresh blow to the Melbourne-based...
New Zealand biotech BioOra will expand production of its next-generation cell therapies to Australia after winning a $7.7 million grant through Queensland’s Sovereign Industry Development Fund. The Wellington-based company...
One of Australia’s most promising BioTechs says it will be torpedoed by a government plan to tighten innovation tax incentives and cap them after 10 years, warning it could...
Australia’s proposed digital duty of care should extend to AI companies, according to Labor senator and former AI startup founder Michelle Ananda-Rajah, who has floated a rights-based approach to...
Startups will focus on scaling and commercialisation in 2026, building off last year’s more optimistic funding environment and a federal government policy shift towards sovereign industry, innovation sector leaders...